|Day Low/High||58.17 / 58.92|
|52 Wk Low/High||42.99 / 58.73|
The RetinaVue 100 Imager costs 75% less than traditional desktop fundus cameras, making diabetic retinal exam technology affordable for the majority of primary care practices
Investors in Hill-Rom Holdings, Inc. saw new options become available today, for the August 19th expiration.
-- System designed to build stronger connections between patients and care teams to help improve therapy adherence --
DHF ENS HRC are going ex-dividend tomorrow, Wednesday, June 08, 2016
Hill-Rom (HRC) stock is retreating on Friday afternoon following disappointing revenue for the 2016 fiscal second quarter and a downbeat forecast.
These 14 inexpensive stocks are expected to have strong top-line growth in the next two years, says Goldman Sachs.
Early Detection Can Prevent 95% of Vision Loss Cases
Hill-Rom and Welch Allyn to showcase strength of combined companies, benefits of connected clinical environments at HIMSS
Looking for safe growth opportunities in this dangerous, volatile market? Consider these highly promising stocks in the booming medical device industry.
These stocks would be the most exposed if the U.S. economy were to fall into a recession, according to Morgan Stanley analysts.
Welch Allyn, a leading medical diagnostic device company that is a division of Hill-Rom (NYSE:HRC), recently introduced three new automated vital signs solutions that can help healthcare providers across Canada...
In trading on Thursday, shares of Hill-Rom Holdings, Inc. crossed below their 200 day moving average of $51.83, changing hands as low as $51.11 per share.
Patients Report Discomfort, Embarrassment, Lack of Respect